(INDIANAPOLIS) - Researchers for Roche say a new, experimental drug is showing promise in raising your good cholesterol.
The study finds that Dalcetrapib raises HDL or "good" cholesterol by about 30 percent compared to placebos.
The study shows it does so without increasing blood pressure or the risk of a heart attack.
However, I.U. Cardiologist Dr. Yazid Fadl says it's still too early to make big claims about what experimental cholesterol drugs can accomplish. Researchers admit that safety problems are making the research process very careful and gradual.
They say they still have a long way to go before an HDL raising drug can be considered safe for consumers.
Meantime, Dr. Fadl says proper diet and exercise can go a long way in shaping healthy cholesterol levels.
Have a question or comment about a news story? Send it to firstname.lastname@example.org